Key result
Interventional procedures for second retroperitoneal sarcoma recurrences linked to ~95% lower mortality risk.
Why the study?
Few data are available regarding the role of surgery in treating retroperitoneal sarcoma recurrences.
Does surgical treatment of recurrent retroperitoneal sarcoma offer survival benefits across different patterns of recurrence?
Cohort (n=33)
Yes
Does surgical treatment of recurrent retroperitoneal sarcoma offer survival benefits across different patterns of recurrence?
Hazard Ratio: 0.046 (95% CI 0.004–0.471)
p-value: p=0.010
Surgical resection of retroperitoneal sarcoma recurrences, including distant metastases and repeated resections, may offer long-term survival benefits and should be considered in multidisciplinary management.
Introduction: Few data are available about the role of surgery in the treatment of retroperitoneal sarcoma (RPS) recurrences. We herein report the short- and mid-term outcomes of patients who underwent surgical treatment of RPS recurrences at two Italian centers. Materials and Methods From January 2005 to January 2020, 33 patients underwent surgical treatment of isolated locally recurrent RPS (LR group), locally recurrent RPS associated with the presence of distant recurrence (LR + DM group), and distant-only recurrent RPS (DM group). Data regarding pre-, intra-, post-operative course, and follow-up, were retrospectively analyzed and compared. Results LR-group was composed of 15 patients, LR + DM group of 9 patients, and DM group of 9 patients. During the follow-up, 78.5% of the LR group, 77.8% of the DM group and 100% of the LR + DM group (p = 0.244) experienced a second recurrence. No differences in the mean disease-free survival (p = 0.127), overall survival (OS) (p = 0.165) was reported between the three groups. Repeated surgery was an independent factor affecting survival in multivariate analysis (p = 0.01). Conclusions A surgical treatment of RPS recurrences should always be taken into consideration, also in metastatic patients and/or in those who have already undergone surgery, because this approach may offer longer survival.
No takes yet. Share an insight, caveat, or question.
Guadagni et al. (2022) conducted a cohort in Recurrent retroperitoneal sarcoma (n=33). Second recurrence interventional procedures (repeated surgery) vs. No interventional procedures for second recurrence was evaluated on Overall survival (HR 0.046, 95% CI 0.004-0.471, p=0.010). In patients with recurrent retroperitoneal sarcoma, undergoing interventional procedures for a second recurrence was independently associated with improved overall survival (HR 0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: